Develops technologies for the welfare of people living with
diabetes. The company's flagship product, the Solo, is a
miniature insulin dispensing patch that is well-adapted to any
daily routine allowing a richer and better-controlled lifestyle
anywhere, anytime.
Employees: 11
Main Markets:
Diabetic Patients.
Overview
Founded in November 2005, MEDINGO LTD. caters specifically to the
Click here to request more information, about this company (FOR COLLABORATION IN R&D. ONLY!)
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please register in this server
Your requests will be forwarded to the developer, who
will contact you directly
You can also see the list of
documents you already requested more information about
needs of insulin-dependent diabetic patients. The MEDINGO device
is a miniature patch-like disposable dispenser, which is far more
convenient, easy to use, discreet and cost-effective than
standard insulin pumps. In addition to insulin delivery, MEDINGO
devices can serve as platforms for other applications, including
pain control and glucose sensing.
Through the unique combination of advanced engineering expertise
and broad scientific collaboration, MEDINGO is working to meet
the requirements and needs of the diabetes community by
introducing miniature devices of superior technology and design .
The company's flagship product, the Solo, is the result of
intensive research and cutting-edge development. The Solo is a
miniature insulin dispensing patch that is well-adapted to any
daily routine allowing a richer and better-controlled lifestyle
anywhere, anytime .
MEDINGO believes that the system will be of interest not only to
diabetics who already use insulin pumps, but also to diabetics
who have chosen not to use insulin pumps for various reasons .
The MEDINGO system enables healthcare professionals to offer
their patients a new solution that is better-tailored to their
requirements, hence appealing to a larger market .
Alongside the benefits to the patient, the MEDINGO system is also
focused on healthcare providers, as the system is designed to
meet all the existing reimbursement codes.
MEDINGO's core technology is based on research and development of
RAFAEL, the primary armament development authority of the Israeli
Department of Defense. This proprietary know-how enables
integration of marketable micro-engines and transceiver chip
technologies.
